[HTML][HTML] A Patient With CKD Develops Cholestatic Liver Injury During a Clinical Trial
EDA Wagener, N Souma, A Hodakowski… - Kidney International …, 2018 - Elsevier
Patients with chronic kidney disease (CKD) develop disordered phosphate metabolism,
characterized by abnormalities in phosphate and fibroblast growth factor 23 (FGF23) levels …
characterized by abnormalities in phosphate and fibroblast growth factor 23 (FGF23) levels …